CAM
ABBV icon

Columbia Asset Management’s AbbVie ABBV Stock Holding History

Columbia Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,184,000
Closed -$1.17M – 172
2025
Q1 		$1.17M Buy
1,184,000
+340,000
+40% +$66.1M 0.23% 74
2024
Q4 		$832K Buy
+844,000
New +$155M 0.15% 103

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Columbia Asset Management's ABBV Position: Q2 2026 in Review

Columbia Asset Management reduced its AbbVie (ABBV) stake by 2.3% in Q2 2026, selling an estimated $173K and leaving 34,525 shares worth $8.69M. The position accounts for 1.51% of the portfolio, ranked #17.

Columbia Asset Management first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $47.7M in Q1 2020. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Columbia Asset Management held 34,525 shares of AbbVie worth $8.69M as of Q2 2026.
  • Columbia Asset Management sold 804 AbbVie shares in Q2 2026, an estimated $173K.
  • AbbVie made up 1.51% of Columbia Asset Management's portfolio in Q2 2026, its #17 holding.
  • Columbia Asset Management first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
  • Columbia Asset Management's AbbVie position peaked at $47.7M in Q1 2020.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.